Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Ladenburg Thalmann Downgrades NextCure to Neutral

Ladenburg Thalmann analyst Aydin Huseynov downgrades NextCure (NASDAQ:NXTC) from Buy to Neutral.
byBenzinga Newsdesk
November 4, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Ladenburg Thalmann analyst Aydin Huseynov downgrades NextCure (NASDAQ:NXTC) from Buy to Neutral.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

US Stocks Poised To Open Lower After Thursday’s Plunge: Can Jobs Data Help Reverse Sentiment?

By Shanthi Rexaline
March 10, 7:18 AM
Trading in the U.S. index futures suggests stocks could extend their sell-off on Friday, although the jobs report due ahead of the market open could change the entire complexion depending on how the numbers shape up. Cues From Thursday’s Trading:

ALK